|
1
|
Veronesi U, Paganelli G, Viale G, et al:
Sentinel lymph node biopsy and axillary dissection in breast
cancer: Results in a large series. J Natl Cancer Inst. 91:368–373.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Goldhirsch A, Ingle JN, Gelber RD, Coates
AS, Thürlimann B and Senn HJ: Panel members: Thresholds for
therapies: Highlights of the St Gallen International Expert
Consensus on the primary therapy of early breast cancer 2009. Ann
Oncol. 20:1319–1329. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lyman GH, Temin S, Edge SB, Newman LA,
Turner RR, Weaver DL, Benson AB III, Bosserman LD, Burstein HJ,
Cody H III, et al: American Society of Clinical Oncology
Clinical Practice: Sentinel lymph node biopsy for patients with
early-stage breast cancer: American Society of Clinical Oncology
clinical practice guideline update. J Clin Oncol. 32:1365–1383.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang YS, Ouyang T, Wang QT, Su FX, Zhu SG,
Wu J, Yu CZ, Cao SS, Wang S and Li JY: The updated result of China
multicenter study of sentinel node biopsy substituting axillary
node dissection: CBCSG-001 trial. Chin J Breast Dis. 3:265–272.
2009.
|
|
5
|
Greene FL, Page DL, Fleming ID, Fritz A,
Balch CM, Haller DG and Morrow M: AJCC Cancer Staging Manual. 6th.
Springer-Verlag; New York: 2002, View Article : Google Scholar
|
|
6
|
Cserni G: Sentinel lymph node biopsy as a
tool for the staging of ductal carcinoma in situ in patients
with breast carcinoma. Surg Today. 32:99–103. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kelly TA, Kim JA, Patrick R, Grundfest S
and Crowe JP: Axillary lymph node metastases in patients with a
final diagnosis of ductal carcinoma in situ. Am J Surg.
186:368–370. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Intra M, Rotmensz N, Veronesi P, Colleoni
M, Iodice S, Paganelli G, Viale G and Veronesi U: Sentinel node
biopsy is not a standard procedure in ductal carcinoma in
situ of the breast: The experience of the European institute of
oncology on 854 patients in 10 years. Ann Surg. 247:315–319. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Farkas EA, Stolier AJ, Teng SC, Bolton JS
and Fuhrman GM: An argument against routine sentinel node mapping
for DCIS. Am Surg. 70:13–17. 2004.PubMed/NCBI
|
|
10
|
Veronesi P, Intra M, Vento AR, Naninato P,
Caldarella P, Paganelli G and Viale G: Sentinel lymph node biopsy
for localised ductal carcinoma in situ? Breast. 14:520–522.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zavagno G, Carcoforo P, Marconato R,
Franchini Z, Scalco G, Burelli P, Pietrarota P, Lise M, Mencarelli
R, Capitanio G, et al: Role of axillary sentinel lymph node biopsy
in patients with pure ductal carcinoma in situ of the
breast. BMC Cancer. 5:282005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Katz A, Gage I, Evans S, Shaffer M, Fleury
T, Smith FP, Flax R, Drogula C, Petrucci P, Magnant C, et al:
Sentinel lymph node positivity of patients with ductal carcinoma
in situ or microinvasive breast cancer. Am J Surg.
191:761–766. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mabry H, Giuliano AE and Silverstein MJ:
What is the value of axillary dissection or sentinel node biopsy in
patients with ductal carcinoma in situ? Am J Surg.
192:455–457. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Leidenius M, Salmenkivi K, von Smitten K
and Heikkilä P: Tumour-positive sentinel node findings in patients
with ductal carcinoma in situ. J Surg Oncol. 94:380–384.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sakr R, Barranger E, Antoine M, Prugnolle
H, Daraï E and Uzan S: Ductal carcinoma in situ: Value of sentinel
lymph node biopsy. J Surg Oncol. 94:426–430. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Di Saverio S, Catena F, Santini D,
Ansaloni L, Fogacci T, Mignani S, Leone A, Gazzotti F, Gagliardi S,
De Cataldis A, et al: 259 patients with DCIS of the breast applying
USC/Van Nuys prognostic index: A retrospective review with long
term follow up. Breast Cancer Res Treat. 109:405–416. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yi M, Krishnamurthy S, Kuerer HM,
Meric-Bernstam F, Bedrosian I, Ross MI, Ames FC, Lucci A, Hwang RF
and Hunt KK: Role of primary tumor characteristics in predicting
positive sentinel lymph nodes in patients with ductal carcinoma
in situ or microinvasive breast cancer. Am J Surg.
196:81–87. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dominguez FJ, Golshan M, Black DM, Hughes
KS, Gadd MA, Christian R, Lesnikoski BA, Specht M, Michaelson J and
Smith BL: Sentinel node biopsy is important in mastectomy for
ductal carcinoma in situ. Ann Surg Oncol. 15:268–273. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tada K, Ogiya A, Kimura K, Morizono H,
Iijima K, Miyagi Y, Nishimura S, Makita M, Horii R, Akiyama F, et
al: Ductal carcinoma in situ and sentinel lymph node
metastasis in breast cancer. World J Surg Oncol. 8:62010.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Miyake T, Shimazu K, Ohashi H, Taguchi T,
Ueda S, Nakayama T, Kim SJ, Aozasa K, Tamaki Y, Noguchi S, et al:
Indication for sentinel lymph node biopsy for breast cancer when
core biopsy shows ductal carcinoma in situ. Am J Surg.
202:59–65. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ozkan-Gurdal S, Cabioglu N, Ozcinar B, et
al: Factors predicting microinvasion in Ductal Carcinoma in
situ. Asian Pac J Cancer Prev. 15:55–60. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zetterlund L, Stemme S, Arnrup H and de
Boniface J: Incidence of and risk factors for sentinel lymph node
metastasis in patients with a postoperative diagnosis of ductal
carcinoma in situ. Br J Surg. 101:488–494. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Klauber-DeMore N, Tan LK, Liberman L,
Kaptain S, Fey J, Borgen P, Heerdt A, Montgomery L, Paglia M,
Petrek JA, et al: Sentinel lymph node biopsy: Is it indicated in
patients with high-risk ductal carcinoma-in-situ and ductal
carcinoma-in-situ with microinvasion? Ann Surg Oncol. 7:636–642.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pendas S, Dauway E, Giuliano R, Ku N, Cox
CE and Reintgen DS: Sentinel node biopsy in ductal carcinoma in
situ patients. Ann Surg Oncol. 7:15–20. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wilkie C, White L, Dupont E, Cantor A and
Cox CE: An update of sentinel lymph node mapping in patients with
ductal carcinoma in situ. Am J Surg. 190:563–566. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mittendorf EA, Arciero CA, Gutchell V,
Hooke J and Shriver CD: Core biopsy diagnosis of ductal carcinoma
in situ: An indication for sentinel lymph node biopsy. Curr Surg.
62:253–257. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Camp R, Feezor R, Kasraeian A, Cendan J,
Schell S, Wilkinson E, Copeland E and Lind S: Sentinel lymph node
biopsy for ductal carcinoma in situ: An evolving approach at
the University of Florida. Breast J. 11:394–397. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yen TW, Hunt KK, Ross MI, Mirza NQ,
Babiera GV, Meric-Bernstam F, Singletary SE, Symmans WF, Giordano
SH, Feig BW, et al: Predictors of invasive breast cancer in
patients with an initial diagnosis of ductal carcinoma in situ: A
guide to selective use of sentinel lymph node biopsy in management
of ductal carcinoma in situ. J Am Coll Surg. 200:516–526.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Takács T, Szentpáli K, Paszt A, et al:
Importance of sentinel lymph node biopsy in surgical therapy of
in situ breast cancer. Pathol Oncol Res. 15:329–333. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Fraile M, Gubern JM, Rull M, et al: Is it
possible to refine the indication for sentinel node biopsy in
high-risk ductal carcinoma in situ? Nucl Med Commun.
27:785–789. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Moran CJ, Kell MR, Flanagan FL, Kennedy M,
Gorey TF and Kerin MJ: Role of sentinel lymph node biopsy in
high-risk ductal carcinoma in situ patients. Am J Surg.
194:172–175. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Meijnen P, Oldenburg HS, Loo CE, Nieweg
OE, Peterse JL and Rutgers EJ: Risk of invasion and axillary lymph
node metastasis in ductal carcinoma in situ diagnosed by
core-needle biopsy. Br J Surg. 94:952–956. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Moore KH, Sweeney KJ, Wilson ME, Goldberg
JI, Buchanan CL, Tan LK, Liberman L, Turner RR, Lagios MD, Cody Iii
HS, et al: Outcomes for women with ductal carcinoma-in-situ and a
positive sentinel node: A multi-institutional audit. Ann Surg
Oncol. 14:2911–2917. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Sakr R, Bezu C, Raoust I, Antoine M,
Ettore F, Darcourt J, Kerrou K, Daraï E, Rouzier R and Uzan S: The
sentinel lymph node procedure for patients with preoperative
diagnosis of ductal carcinoma in situ: Risk factors for unsuspected
invasive disease and for metastatic sentinel lymph nodes. Int J
Clin Pract. 62:1730–1735. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
van la Parra RF, Ernst MF, Barneveld PC,
Broekman JM, Rutten MJ and Bosscha K: The value of sentinel lymph
node biopsy in ductal carcinoma in situ (DCIS) and DCIS with
microinvasion of the breast. Eur J Surg Oncol. 34:631–635. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Doyle B, Al-Mudhaffer M, Kennedy MM,
O'Doherty A, Flanagan F, McDermott EW, Kerin MJ, Hill AD and Quinn
CM: Sentinel lymph node biopsy in patients with a needle core
biopsy diagnosis of ductal carcinoma in situ: Is it justified? J
Clin Pathol. 62:534–538. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Schneider C, Trocha S, McKinley B, Shaw J,
Bielby S, Blackhurst D, Jones Y and Cornett W: The use of sentinel
lymph node biopsy in ductal carcinoma in situ. Am Surg. 76:943–946.
2010.PubMed/NCBI
|
|
38
|
Kurniawan ED, Rose A, Mou A, Buchanan M,
Collins JP, Wong MH, Miller JA and Mann GB: Risk factors for
invasive breast cancer when core needle biopsy shows ductal
carcinoma in situ. Arch Surg. 145:1098–1104. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Son BK, Bong JG, Park SH and Jeong YJ:
Ductal carcinoma in situ and sentinel lymph node biopsy. J
Breast Cancer. 14:301–307. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Chin-Lenn L, Mack LA, Temple W, Cherniak
W, Quinn RR, Ravani P, Lewin AM and Quan ML: Predictors of
treatment with mastectomy, use of sentinel lymph node biopsy and
upstaging to invasive cancer in patients diagnosed with breast
ductal carcinoma in situ (DCIS) on core biopsy. Ann Surg
Oncol. 21:66–73. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Guillot E, Vaysse C, Goetgeluck J, Falcou
MC, Couturaud B, Fitoussi A, Fourchotte V, Laki F, Malhaire C and
Sigal-Zafrani B: Extensive pure ductal carcinoma in situ of
the breast: Identification of predictors of associated infiltrating
carcinoma and lymph node metastasis before immediate reconstructive
surgery. Breast. 23:97–103. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Osako T, Iwase T, Ushijima M, Horii R,
Fukami Y, Kimura K, Matsuura M and Akiyama F: Incidence and
prediction of invasive disease and nodal metastasis in
preoperatively diagnosed ductal carcinoma in situ. Cancer
Sci. 105:576–582. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Rutstein LA, Johnson RR, Poller WR, Dabbs
D, Groblewski J, Rakitt T, Tsung A, Kirchner T, Sumkin J, Keenan D,
et al: Predictors of residual invasive disease after core needle
biopsy diagnosis of ductal carcinoma in situ. Breast J.
13:251–257. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Goyal A, Douglas-Jones A, Monypenny I,
Sweetland H, Stevens G and Mansel RE: Is there a role of sentinel
node biopsy in ductal carcinoma in situ?: analysis of 587
cases. Breast Cancer Res Treat. 98:311–314. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Huo L, Sneige N, Hunt KK, Albarracin CT,
Lopez A and Resetkova E: Predictors of invasion in patients with
core-needle biopsy-diagnosed ductal carcinoma in situ and
recommendations for a selective approach to sentinel lymph node
biopsy in ductal carcinoma in situ. Cancer. 107:1760–1768.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hoorntje LE, Schipper ME, Peeters PH,
Bellot F, Storm RK and Borel Rinkes IH: The finding of invasive
cancer after a preoperative diagnosis of ductal carcinoma-in-situ:
Causes of ductal carcinoma-in-situ underestimates with stereotactic
14-gauge needle biopsy. Ann Surg Oncol. 10:748–753. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Renshaw AA: Predicting invasion in the
excision specimen from breast core needle biopsy specimens with
only ductal carcinoma in situ. Arch Pathol Lab Med.
126:39–41. 2002.PubMed/NCBI
|
|
48
|
Jackman RJ, Burbank F, Parker SH III,
Evans WP III, Lechner MC, Richardson TR, Smid AA, Borofsky HB, Lee
CH, Goldstein HM, et al: Stereotactic breast biopsy of nonpalpable
lesions: determinants of ductal carcinoma in situ
underestimation rates. Radiology. 218:497–502. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
King TA, Farr GH Jr, Cederbom GJ,
Smetherman DH, Bolton JS, Stolier AJ and Fuhrman GM: A mass on
breast imaging predicts coexisting invasive carcinoma in patients
with a core biopsy diagnosis of ductal carcinoma in situ. Am
Surg. 67:907–912. 2001.PubMed/NCBI
|
|
50
|
Lee CH, Carter D, Philpotts LE, Couce ME,
Horvath LJ, Lange RC and Tocino I: Ductal carcinoma in situ
diagnosed with stereotactic core needle biopsy: Can invasion be
predicted? Radiology. 217:466–470. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Trentin C, Dominelli V, Maisonneuve P,
Menna S, Bazolli B, Luini A and Cassano E: Predictors of invasive
breast cancer and lymph node involvement in ductal carcinoma in
situ initially diagnosed by vacuum-assisted breast biopsy:
Experience of 733 cases. Breast. 21:635–640. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Lee SK, Yang JH, Woo SY, Lee JE and Nam
SJ: Nomogram for predicting invasion in patients with a
preoperative diagnosis of ductal carcinoma in situ of the
breast. Br J Surg. 100:1756–1763. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Park HS, Park S, Cho J, Park JM, Kim SI
and Park BW: Risk predictors of underestimation and the need for
sentinel node biopsy in patients diagnosed with ductal carcinoma
in situ by preoperative needle biopsy. J Surg Oncol.
107:388–392. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Schulz S, Sinn P, Golatta M, Rauch G,
Junkermann H, Schuetz F, Sohn C and Heil J: Prediction of
underestimated invasiveness in patients with ductal carcinoma in
situ of the breast on percutaneous biopsy as rationale for
recommending concurrent sentinel lymph node biopsy. Breast.
22:537–542. 2013. View Article : Google Scholar : PubMed/NCBI
|
